425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive's CEO posting a communication on X.com.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was posted by Matthew Cole, CEO of Strive, Inc., on September 23, 2025.
• The transaction involves Strive issuing additional shares of its Class A common stock.
• A Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, will be filed with the SEC.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant corporate event (merger) which is generally positive for growth prospects, but it is heavily weighted with extensive cautionary statements and risks, leading to a neutral-to-slightly-positive sentiment rather than strongly positive.

Positives

• Anticipated strategic benefits from the proposed transaction.
• Expected financial benefits from the proposed transaction.
• Anticipated cost savings and strategic gains from the integration of businesses.

Negatives

• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from Strive's or Semler Scientific's customers.
• Potential changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific.
• The proposed transaction may not close when expected or at all due to unfulfilled conditions.
• Potential legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact outcomes.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Other unknown or unpredictable factors could harm the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits, including cost savings and strategic gains, from the proposed business combination. However, they also acknowledge that actual results could differ materially from expectations due to various risks and uncertainties.

Management Comments

• Matthew Cole, CEO of Strive, Inc., communicated about the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating Semler Scientific's involvement in or exposure to the digital asset space, which is a significant and evolving trend in corporate finance and investment.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Related Party Transactions

• Information regarding Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders (not detailed in this filing).

Stakeholder Impact

• Shareholders of Strive face dilution due to the issuance of new Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships could change as a result of the announcement or completion of the transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific, business combination, merger, acquisition, SEC filing, Form 425, Bitcoin treasury, digital assets, corporate governance, risk management